Safety Needles

BD AutoShield™ Duo Pen Needle

About BD AutoShield™ Duo Pen Needle  |   BD AutoShield™ Duo Pen Compatibility
For Materials Management  |  For Hospital Pharmacy

Clinical efficacy. Simplicity.

BD AutoShield™ Duo is the only pen needle that offers the unique benefits of a 5mm needle.

• 5mm needles are shown to provide equivalent glycemic control to longer needles, regardless of patient BMI^1,2,3
• Recent injection guidelines recommend 5mm needles for insulin injection⁴
• Shorter needles eliminate “pinch” technique, which is a
  common source of needlestick injuries
• Evaluating Duo can help meet OSHA’s requirement to
  evaluate safer devices as they become available⁵

Reducing risk of IM injections improves glycemic control.

It’s the only one you need.

BD is the only pen needle manufacturer that fits every diabetes pen⁸,
and the only pen needle that eliminates “pinch up” injection technique.

Email BD or call 1-888-356-3241 to:

• Request more information about how BD AutoShield™ Duo can benefit your facility
• Schedule a demonstration
• Learn how BD’s training and in-service support can aid staff uptake

BD AutoShield™ Duo Pen Needle

¹ Kreugel G, Keers JC, Jongbloed A, Wolffenbuttel BHR. Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes. Diab Tech Ther 2011;13(7): DOI: 10.1089/dia.2011.0010.

² Kreugel G, Beijer HJM, Kerstens MN, Maaten ter JC, Sluiter WJ, Boot BS. Influence of needle size for subcutaneous insulin administration on metabolic control and patient acceptance. European Diabetes Nursing. 2007: Vol. 4 No. 2.

³ Kreugel G, Keers JC, Jongbloed A, et al. The influence of needle length on glycemic control and patient preference in obese diabetic patients. Diabetes. 2009; 58(S1): 440.

⁴ Frid, A, et. al: New injection recommendations for patients with diabetes. Diabetes & Metabolism 2010;36: S3-S18.

⁵ OSHA Bloodborne Pathogen Standard: 29 CFR §1910.1030(c) (1)(iv), paragraphs (A) and (B).

⁶ Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010; 26 (6): 1519–1530.

⁷ Karges B, Boehm BO, Karges W. Early hypoglycaemia after accidental intramuscular injection of insulin glargine. Diabet Med. 2005 Oct;22(10):1444-5.

⁸ Data on file at BD as of August 2011.